MICHELE HAMPTON: Open Payments
NPI 1508886151 · FLOWER MOUND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,323 in 51 payments from 14 companies in 2025. Trend: 2023 $1,164 · 2024 $1,349 · 2025 $1,323
Food & beverage: $1,323
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $349 |
| Corcept Therapeutics | 7 | $207 |
| AstraZeneca Pharmaceuticals LP | 11 | $195 |
| ABBVIE INC. | 7 | $152 |
| SANOFI-AVENTIS U.S. LLC | 1 | $112 |
| Otsuka America Pharmaceutical, Inc. | 4 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $53 |
| Esperion Therapeutics, Inc. | 3 | $43 |
| Phathom Pharmaceuticals, Inc. | 3 | $27 |
| Verity Pharmaceuticals Inc. | 1 | $26 |
Products named: Ozempic, Korlym, FARXIGA, Wegovy, QULIPTA, TZIELD, REXULTI, JARDIANCE.
Industry payments across TX — which companies pay providers there.
